ArticleCureus2026
Analysis of Myelodysplastic Neoplasia: Epidemiological and Biological Characteristics Based on 20 Clinical Cases and a Literature Review.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myelodysplastic neoplasia (MDS) is a hematological malignancy characterized by inefficient hematopoiesis, responsible for quantitative and qualitative abnormalities of the three myeloid cell lineages, classically revealed by peripheral cytopenias and an increased risk of transformation into acute myeloid leukemia (AML). The diagnosis of these conditions is sometimes difficult, complex, and time-consuming, potentially requiring multiple examinations, relying primarily on complete blood count (CBC) data and the results of semi-quantitative and qualitative analysis of the bone marrow aspirate. Our objective through this study is to determine the epidemiological and biological profile of MDS. We included 20 patients presenting with MDS diagnosed on CBC and bone marrow aspirate analysis. Within our population, male predominance was observed, with a mean age of 61 years. Biologically, the CBC demonstrated the presence of anemia in 83.33% of cases with a mean hemoglobin concentration of 7.92 g/dl. Furthermore, thrombocytopenia was detected in 55.55%, while neutropenia was observed in only 44.44% of patients. Using the World Health Organization (WHO) 2022 classification, the entity of MDS with few blasts and multilineage dysplasia (MDS-LB-MLD) was the most frequently detected in our study (35%). According to cytogenetic analysis results, a single case of 5q- syndrome and one case of chromosome 7q deletion were identified among the 13 studies performed on all patients. Recently, MDS has attracted increased attention, particularly regarding diagnostic, prognostic, and therapeutic criteria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.